NCT04507386

Brief Summary

This research program aims to comprehensively investigate the clinical, physiological, metabolic, and molecular effects of reducing sedentary behavior in patients with mild cognitive impairment. A 4-month parallel-group randomized controlled trial will be conducted aiming to investigate the feasibility and efficacy of a newly developed personalized intervention focused on replacing sedentary time with light-(or very light-) intensity physical activity in patients with mild cognitive impairment. Additionally, a sub-sample of patients will complete a randomised cross-over study aiming to unravel potential mechanisms underlying the metabolic, physiological and molecular effects of breaking up sedentary time with light-intensity physical activity versus carrying out the minimum amount of daily exercise at once and then remaining sedentary versus simply remaining sedentary throughout all sessions, in a well-controlled laboratorial condition.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2020

Longer than P75 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 30, 2020

Completed
2 days until next milestone

Study Start

First participant enrolled

August 1, 2020

Completed
10 days until next milestone

First Posted

Study publicly available on registry

August 11, 2020

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2024

Completed
Last Updated

August 17, 2020

Status Verified

August 1, 2020

Enrollment Period

4 years

First QC Date

July 30, 2020

Last Update Submit

August 13, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Sedentary behaviour assessed by ActivPAL™

    4 months

Secondary Outcomes (25)

  • Physical activity levels assessed by ActiGraph GT3X®

    4 months

  • Cognitive performance assessed by the Montreal Cognitive Assessment (MoCA)

    4 months

  • Cognitive decline assessed by the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE)

    4 months

  • Subjective memory complaints assessed by the Memory Complaint Scale (MCS)

    4 months

  • Functional impairments in activities of daily living assessed by the Functional Activities Questionnaire (FAQ)

    4 months

  • +20 more secondary outcomes

Study Arms (2)

Take a STAND for health

EXPERIMENTAL

A newly developed personalized intervention focused on replacing sedentary time with light-(or very light-) intensity physical activity

Behavioral: Take a STAND for health

Control

NO INTERVENTION

The control group will receive regular medical care and advice on healthy lifestyle, including physical activity and healthy eating recommendations

Interventions

The Take a STAND for health is a newly developed 4-month goal-setting intervention aimed at reducing sedentary behavior

Take a STAND for health

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Middle-aged and older adults with mild cognitive impairment confirmed by a team of neurologists from the CEREDIC HC-FMUSP

You may not qualify if:

  • Patients who spend less than 8 hours per day in sedentary time
  • Patients who are physically active (more than 150 min/week of moderate physical activity, or more than 75 min/week of vigorous activity)
  • Patients who are functional illiterates
  • Patients with history or clinical diagnosis of neurological diseases
  • Patients with severe psychiatric symptoms
  • Patients taking antidepressants
  • Patients with visual and/or hearing impairments that prevent participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Cognitive Dysfunction

Interventions

Health

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Population Characteristics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A 4-month parallel-group randomised controlled trial will be performed, in which patients with mild cognitive impairment will be assessed at baseline (PRE) and after 4 months (POST). Moreover, a sub-sample of patients will perform a randomised crossover trial at baseline (PRE). Patients will complete three experimental sessions in a random manner, as follows: Prolonged sitting (SIT), in which participants engaged in prolonged sitting throughout an 5-h period and were instructed to minimize excessive movement; Exercise followed by prolonged sitting (EX), in which participants performed a 30-min moderate-to-vigorous exercise bout on a treadmill, subsequently, participants engaged in prolonged sitting as described for SIT; Light-intensity breaks (BR), in which participants completed a 3-min bout of light-intensity walking every 30 min of sitting throughout the experimental period.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 30, 2020

First Posted

August 11, 2020

Study Start

August 1, 2020

Primary Completion

August 1, 2024

Study Completion

August 1, 2024

Last Updated

August 17, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will not share